Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioGeneration Ventures

Founders Edward van Wezel

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 51
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 35
Rounds per year 2.83
Lead investments 10
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.31
Exits 6
Key employees 6
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Pharmaceutical
Summary

In 2006 was created BioGeneration Ventures, which is appeared as VC. The main office of represented VC is situated in the Naarden. The company was established in Europe in The Netherlands.

The top amount of exits for fund were in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this BioGeneration Ventures performs on 10 percentage points less the average number of lead investments. Considering the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BioGeneration Ventures, startups are often financed by Thuja Capital, NV NOM, MedSciences Capital. The meaningful sponsors for the fund in investment in the same round are Forbion Capital Partners, New Science Ventures, BOM Capital. In the next rounds fund is usually obtained by Omnes Capital, Forbion Capital Partners, Erasmus MC Biomedical Fund.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Mellon Medical, Scenic Biotech. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Therapeutics, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands.

Besides them, we counted 5 critical employees of this fund in our database.

Read more

Funds with similar focus

Funds from The Netherlands
Funds with similar focus located in The Netherlands:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

VectorY

$152M13 Nov 2023 -

Tessellate BIO

Biotechnology
Medical
Product Research
$9M17 Oct 2023 Naarden, Noord-Holland, The Netherlands

Mironid

Ad Network
Biotechnology
Health Diagnostics
Therapeutics
$42M13 Sep 2023 United Kingdom, Scotland, United Kingdom

VarmX

Manufacturing
Pharmaceutical
Therapeutics
$41M25 May 2023 Leiden, South Holland, Netherlands

Dualyx

Biotechnology
Health Care
Medical
$47M15 May 2023 Ghent, Oost-Vlaanderen, Belgium

Complement Therapeutics

Biotechnology
Medical
$84M17 Apr 2023 London, England, United Kingdom

Panome Bio

$6M24 Feb 2023 St Louis, Missouri, United States

Catalym

Therapeutics
$59M22 Nov 2022 Munich, Bavaria, Germany

FundaMental Pharma

Health Care
$11M17 Nov 2022 Heidelberg, Baden-Wurttemberg, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioGeneration Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 51
Average round size 20M
Rounds per year 2.83
Peak activity year 2020
Lead investments 10
Follow on index 0.31
Exits 6
Group Appearance index 0.78

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

VectorY

$152M13 Nov 2023 -

Tessellate BIO

Biotechnology
Medical
Product Research
$9M17 Oct 2023 Naarden, Noord-Holland, The Netherlands

Mironid

Ad Network
Biotechnology
Health Diagnostics
Therapeutics
$42M13 Sep 2023 United Kingdom, Scotland, United Kingdom

VarmX

Manufacturing
Pharmaceutical
Therapeutics
$41M25 May 2023 Leiden, South Holland, Netherlands

Dualyx

Biotechnology
Health Care
Medical
$47M15 May 2023 Ghent, Oost-Vlaanderen, Belgium

Complement Therapeutics

Biotechnology
Medical
$84M17 Apr 2023 London, England, United Kingdom

Panome Bio

$6M24 Feb 2023 St Louis, Missouri, United States

Catalym

Therapeutics
$59M22 Nov 2022 Munich, Bavaria, Germany

FundaMental Pharma

Health Care
$11M17 Nov 2022 Heidelberg, Baden-Wurttemberg, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: